结合exergames的虚拟现实康复对帕金森病功能康复的有效性:一项慢性随机对照试验的系统综述。

IF 3.4 2区 医学 Q2 CLINICAL NEUROLOGY
João Lucas Lima, Pedro Augusto Inacio, Alberto Sá Filho, Flávia Paes, Rafael Ferreira-Garcia, Lucio Lage, Vicente Aprigliano, Mauro Giovani Carta, Henning Budde, Antonio Egidio Nardi, Sergio Machado
{"title":"结合exergames的虚拟现实康复对帕金森病功能康复的有效性:一项慢性随机对照试验的系统综述。","authors":"João Lucas Lima, Pedro Augusto Inacio, Alberto Sá Filho, Flávia Paes, Rafael Ferreira-Garcia, Lucio Lage, Vicente Aprigliano, Mauro Giovani Carta, Henning Budde, Antonio Egidio Nardi, Sergio Machado","doi":"10.1080/14737175.2025.2559180","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Exergaming is increasingly used to target gait and balance impairments in Parkinson's disease (PD), but the durability of effects and comparative efficacy versus active controls remain uncertain. The aim of this work is to evaluate the effectiveness and clinical implications of exergame-based rehabilitation for individuals with PD in randomized controlled trials, including studies with and without follow-up assessments.</p><p><strong>Methods: </strong>The authors conducted a PRISMA-guided systematic review (PROSPERO CRD42025642840). Eligible studies were RCTs in people with PD comparing exergaming programs with non-exergaming interventions.</p><p><strong>Results: </strong>Eighteen RCTs (<i>n</i> = 699; 341 exergaming, 358 control) met inclusion criteria; Typical programs spanned 4-12 weeks with 15-60-min sessions, most commonly 6 weeks, delivered predominantly under supervision. The outcomes that improved most consistently were mobility/locomotion (TUG, 6MWT/10MWT, gait speed) and balance. When exergames were compared with active, non-exergaming therapy, effects were generally comparable. Adverse events were rare, and adherence was documented as high where reported; most trials were facility-based with professional supervision. Only three trials included follow-up (≈1-2 months), suggesting short-term retention (~30 days), whereas one 60-day assessment showed return to baseline.</p><p><strong>Conclusion: </strong>Exergame is a safe, feasible, and effective adjunct for short-term improvement of mobility and balance in PD. However, scarce follow-up limit inferences on long-term maintenance.</p>","PeriodicalId":12190,"journal":{"name":"Expert Review of Neurotherapeutics","volume":" ","pages":"1-14"},"PeriodicalIF":3.4000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson's disease: a systematic review of chronic randomized controlled trials.\",\"authors\":\"João Lucas Lima, Pedro Augusto Inacio, Alberto Sá Filho, Flávia Paes, Rafael Ferreira-Garcia, Lucio Lage, Vicente Aprigliano, Mauro Giovani Carta, Henning Budde, Antonio Egidio Nardi, Sergio Machado\",\"doi\":\"10.1080/14737175.2025.2559180\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Exergaming is increasingly used to target gait and balance impairments in Parkinson's disease (PD), but the durability of effects and comparative efficacy versus active controls remain uncertain. The aim of this work is to evaluate the effectiveness and clinical implications of exergame-based rehabilitation for individuals with PD in randomized controlled trials, including studies with and without follow-up assessments.</p><p><strong>Methods: </strong>The authors conducted a PRISMA-guided systematic review (PROSPERO CRD42025642840). Eligible studies were RCTs in people with PD comparing exergaming programs with non-exergaming interventions.</p><p><strong>Results: </strong>Eighteen RCTs (<i>n</i> = 699; 341 exergaming, 358 control) met inclusion criteria; Typical programs spanned 4-12 weeks with 15-60-min sessions, most commonly 6 weeks, delivered predominantly under supervision. The outcomes that improved most consistently were mobility/locomotion (TUG, 6MWT/10MWT, gait speed) and balance. When exergames were compared with active, non-exergaming therapy, effects were generally comparable. Adverse events were rare, and adherence was documented as high where reported; most trials were facility-based with professional supervision. Only three trials included follow-up (≈1-2 months), suggesting short-term retention (~30 days), whereas one 60-day assessment showed return to baseline.</p><p><strong>Conclusion: </strong>Exergame is a safe, feasible, and effective adjunct for short-term improvement of mobility and balance in PD. However, scarce follow-up limit inferences on long-term maintenance.</p>\",\"PeriodicalId\":12190,\"journal\":{\"name\":\"Expert Review of Neurotherapeutics\",\"volume\":\" \",\"pages\":\"1-14\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Neurotherapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14737175.2025.2559180\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Neurotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737175.2025.2559180","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

运动疗法越来越多地用于帕金森病(PD)的步态和平衡障碍,但效果的持久性和与主动对照的比较疗效仍不确定。这项工作的目的是在随机对照试验中评估基于练习的康复治疗对PD患者的有效性和临床意义,包括有和没有随访评估的研究。方法:作者进行了prisma引导的系统评价(PROSPERO CRD42025642840)。符合条件的研究是在PD患者中比较运动项目和非运动干预的随机对照试验。结果:18项rct (n = 699,对照组341,对照组358)符合纳入标准;典型的课程为期4-12周,每次15-60分钟,最常见的是6周,主要在监督下交付。改善最一致的结果是移动性/运动(TUG, 6MWT/10MWT,步态速度)和平衡。当运动疗法与积极的非运动疗法进行比较时,效果通常是可比性的。不良事件很少发生,在报告的地方,依从性记录很高;大多数试验都是在专业监督下进行的。只有三个试验包括随访(≈1-2个月),表明短期保留(~30天),而一个60天的评估显示恢复到基线。结论:Exergame是一种安全、可行、有效的短期改善PD患者活动能力和平衡能力的辅助药物。然而,缺乏随访限制了长期维持的推断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson's disease: a systematic review of chronic randomized controlled trials.

Introduction: Exergaming is increasingly used to target gait and balance impairments in Parkinson's disease (PD), but the durability of effects and comparative efficacy versus active controls remain uncertain. The aim of this work is to evaluate the effectiveness and clinical implications of exergame-based rehabilitation for individuals with PD in randomized controlled trials, including studies with and without follow-up assessments.

Methods: The authors conducted a PRISMA-guided systematic review (PROSPERO CRD42025642840). Eligible studies were RCTs in people with PD comparing exergaming programs with non-exergaming interventions.

Results: Eighteen RCTs (n = 699; 341 exergaming, 358 control) met inclusion criteria; Typical programs spanned 4-12 weeks with 15-60-min sessions, most commonly 6 weeks, delivered predominantly under supervision. The outcomes that improved most consistently were mobility/locomotion (TUG, 6MWT/10MWT, gait speed) and balance. When exergames were compared with active, non-exergaming therapy, effects were generally comparable. Adverse events were rare, and adherence was documented as high where reported; most trials were facility-based with professional supervision. Only three trials included follow-up (≈1-2 months), suggesting short-term retention (~30 days), whereas one 60-day assessment showed return to baseline.

Conclusion: Exergame is a safe, feasible, and effective adjunct for short-term improvement of mobility and balance in PD. However, scarce follow-up limit inferences on long-term maintenance.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Expert Review of Neurotherapeutics
Expert Review of Neurotherapeutics Medicine-Neurology (clinical)
CiteScore
7.00
自引率
2.30%
发文量
61
审稿时长
4-8 weeks
期刊介绍: Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer''s and Parkinson''s. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信